Paragon Genomics, Inc.

About:

provide high-quality target enrichment solutions to the genomics community to advance precision medicine and research

Website: https://www.paragongenomics.com/

Twitter/X: paragongenomics

Top Investors: Cowin Venture, Wisemont Capital, StartX (Stanford-StartX Fund), HEDA Ventures, Fosun Industrial Co

Description:

At Paragon Genomics, we develop and commercialize rapid, easy-to-use, ultra-high multiplex PCR-based target enrichment solutions for Next-Generation Sequencing (NGS). Our proprietary CleanPlex® background-removing technology enables NGS customers to develop targeted sequencing assays that are accurate, sensitive, and simple, yet cost effective. Our technology is applicable to many fast-growing NGS segments such as cancer research, liquid biopsy, biomarker discovery, genomics-guided breeding, companion diagnostics, and immunotherapy monitoring.